Across TCGA pan-cancer cohorts, LINC01793 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of LINC01793’s most consistent transcriptional readouts.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where LINC01793 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC01793 is over-expressed in tumor, although a few such as THCA show the opposite, repressed pattern.

LIHC and THCA are the cancer types where LINC01793 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC01793 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LIHC	All	All	+0.136	.010	1	view →
THCA	Female	All	−0.014	.039	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: LINC01793 RNA expression & survival · all LINC01793 data types